Skip to content

24-hour Urinary Electrolyte Excretion in Chronic Kidney Disease

24-hour Urinary Electrolyte Excretion and Renal Prognosis in Chronic Kidney Disease:a Retrospective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05550467
Enrollment
10000
Registered
2022-09-22
Start date
2014-01-01
Completion date
2022-07-31
Last updated
2022-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Diseases, Electrolyte Imbalance

Brief summary

Association between excretion pattern and development trajectory of urinary electrolytes (urine sodium, urine potassium, urine chlorine, urine magnesium, urine calcium, urine phosphorus, urine creatinine, urea, uric acid, urine glucose, urine protein, urine retinol) and adverse prognosis in patients with chronic kidney disease

Interventions

None listed

Sponsors

Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Our study is a retrospective cohort study. The study included patients with adult(Age≥18years)CKD who were hospitalized in the Department of Nephrology, First Medical Center of Chinese PLA General Hospital from January 2014 to July 2022. Patients with CKD who had one or more 24-hour urinary electrolyte excretion tests at intervals of more than three months were included in the subgroup analysis.

Exclusion criteria

* Patients with hemodialysis therapy and urine volume less than 500ml were excluded.

Design outcomes

Primary

MeasureTime frameDescription
Kidney disease progression2014.1.1-2022.7.31eGFR decline \> 50%; dialysis; kidney transplant
Death2014.1.1-2022.7.31All cause death

Secondary

MeasureTime frameDescription
Cardiovascular disease2014.1.1-2022.7.31myocardial infarction, angina pectoris, stable heart failure, peripheral artery disease , revascularization, cerebrovascular events

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026